148 related articles for article (PubMed ID: 38456480)
1. Norcantharidin inhibits the malignant progression of cervical cancer by inducing endoplasmic reticulum stress.
Zhang Z; Sun B; Lu J; Bai P; Su Y; Li Y
Mol Med Rep; 2024 May; 29(5):. PubMed ID: 38456480
[TBL] [Abstract][Full Text] [Related]
2. Norcantharidin combined with paclitaxel induces endoplasmic reticulum stress mediated apoptotic effect in prostate cancer cells by targeting SIRT7 expression.
Wu MH; Hui SC; Chen YS; Chiou HL; Lin CY; Lee CH; Hsieh YH
Environ Toxicol; 2021 Nov; 36(11):2206-2216. PubMed ID: 34272796
[TBL] [Abstract][Full Text] [Related]
3. Induction of endoplasmic reticulum stress and mitochondrial dysfunction dependent apoptosis signaling pathway in human renal cancer cells by norcantharidin.
Wu MH; Chiou HL; Lin CL; Lin CY; Yang SF; Hsieh YH
Oncotarget; 2018 Jan; 9(4):4787-4797. PubMed ID: 29435141
[TBL] [Abstract][Full Text] [Related]
4. Norcantharidin inhibits proliferation and promotes apoptosis via c-Met/Akt/mTOR pathway in human osteosarcoma cells.
Mei L; Sang W; Cui K; Zhang Y; Chen F; Li X
Cancer Sci; 2019 Feb; 110(2):582-595. PubMed ID: 30520540
[TBL] [Abstract][Full Text] [Related]
5. Norcantharidin inhibits growth of human gallbladder carcinoma xenografted tumors in nude mice by inducing apoptosis and blocking the cell cycle in vivo.
Fan YZ; Zhao ZM; Fu JY; Chen CQ; Sun W
Hepatobiliary Pancreat Dis Int; 2010 Aug; 9(4):414-22. PubMed ID: 20688607
[TBL] [Abstract][Full Text] [Related]
6. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.
Li XP; Jing W; Sun JJ; Liu ZY; Zhang JT; Sun W; Zhu W; Fan YZ
BMC Cancer; 2015 Jul; 15():527. PubMed ID: 26187792
[TBL] [Abstract][Full Text] [Related]
7. Norcantharidin induces anoikis through Jun-N-terminal kinase activation in CT26 colorectal cancer cells.
Chen YJ; Kuo CD; Tsai YM; Yu CC; Wang GS; Liao HF
Anticancer Drugs; 2008 Jan; 19(1):55-64. PubMed ID: 18043130
[TBL] [Abstract][Full Text] [Related]
8. Norcantharidin preferentially induces apoptosis in human leukemic Jurkat cells without affecting viability of normal blood mononuclear cells.
Liao HF; Su SL; Chen YJ; Chou CH; Kuo CD
Food Chem Toxicol; 2007 Sep; 45(9):1678-87. PubMed ID: 17442474
[TBL] [Abstract][Full Text] [Related]
9. Norcantharidin modulates the miR-30a/Metadherin/AKT signaling axis to suppress proliferation and metastasis of stromal tumor cells in giant cell tumor of bone.
Chen F; Wang S; Wei Y; Wu J; Huang G; Chen J; Shi J; Xia J
Biomed Pharmacother; 2018 Jul; 103():1092-1100. PubMed ID: 29710674
[TBL] [Abstract][Full Text] [Related]
10. Norcantharidin induces mitochondrial-dependent apoptosis through Mcl-1 inhibition in human prostate cancer cells.
Lin CL; Chen CM; Lin CL; Cheng CW; Lee CH; Hsieh YH
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1867-1876. PubMed ID: 28760656
[TBL] [Abstract][Full Text] [Related]
11. Norcantharidin induces apoptosis in HeLa cells through caspase, MAPK, and mitochondrial pathways.
An WW; Gong XF; Wang MW; Tashiro S; Onodera S; Ikejima T
Acta Pharmacol Sin; 2004 Nov; 25(11):1502-8. PubMed ID: 15525474
[TBL] [Abstract][Full Text] [Related]
12. Norcantharidin triggers cell death and DNA damage through S-phase arrest and ROS-modulated apoptotic pathways in TSGH 8301 human urinary bladder carcinoma cells.
Yu CC; Ko FY; Yu CS; Lin CC; Huang YP; Yang JS; Lin JP; Chung JG
Int J Oncol; 2012 Sep; 41(3):1050-60. PubMed ID: 22684608
[TBL] [Abstract][Full Text] [Related]
13. Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways.
Zheng LC; Yang MD; Kuo CL; Lin CH; Fan MJ; Chou YC; Lu HF; Huang WW; Peng SF; Chung JG
Anticancer Res; 2016 Nov; 36(11):6031-6042. PubMed ID: 27793930
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of norcantharidin on the growth of human gallbladder carcinoma GBC-SD cells in vitro.
Fan YZ; Fu JY; Zhao ZM; Chen CQ
Hepatobiliary Pancreat Dis Int; 2007 Feb; 6(1):72-80. PubMed ID: 17287171
[TBL] [Abstract][Full Text] [Related]
15. Effector mechanisms of norcantharidin-induced mitotic arrest and apoptosis in human hepatoma cells.
Chen YN; Chen JC; Yin SC; Wang GS; Tsauer W; Hsu SF; Hsu SL
Int J Cancer; 2002 Jul; 100(2):158-65. PubMed ID: 12115564
[TBL] [Abstract][Full Text] [Related]
16. Norcantharidin induces G2/M arrest and apoptosis via activation of ERK and JNK, but not p38 signaling in human renal cell carcinoma ACHN cells.
Huang S; Tuergong G; Zhu H; Wang X; Weng G; Ren Y
Acta Pharm; 2021 Jun; 71(2):267-278. PubMed ID: 33151174
[TBL] [Abstract][Full Text] [Related]
17. Norcantharidin Inhibits cell growth by suppressing the expression and phosphorylation of both EGFR and c-Met in human colon cancer cells.
Qiu P; Wang S; Liu M; Ma H; Zeng X; Zhang M; Xu L; Cui Y; Xu H; Tang Y; He Y; Zhang L
BMC Cancer; 2017 Jan; 17(1):55. PubMed ID: 28086832
[TBL] [Abstract][Full Text] [Related]
18. Norcantharidin: a potential antiangiogenic agent for gallbladder cancers in vitro and in vivo.
Zhang JT; Fan YZ; Chen CQ; Zhao ZM; Sun W
Int J Oncol; 2012 May; 40(5):1501-14. PubMed ID: 22200632
[TBL] [Abstract][Full Text] [Related]
19. Primary in vitro and in vivo evaluation of norcantharidin-chitosan/poly (vinyl alcohol) for cancer treatment.
Li M; Xu X; Lu F; Guo S
Drug Deliv; 2014 Jun; 21(4):293-301. PubMed ID: 24156408
[TBL] [Abstract][Full Text] [Related]
20. Norcantharidin induces melanoma cell apoptosis through activation of TR3 dependent pathway.
Liu S; Yu H; Kumar SM; Martin JS; Bing Z; Sheng W; Bosenberg M; Xu X
Cancer Biol Ther; 2011 Dec; 12(11):1005-14. PubMed ID: 22123174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
